Susan Combs Scott, MD
@SusanScottMD
Followers
895
Following
2K
Media
13
Statuses
391
Thoracic Medical Oncologist at Johns Hopkins at Sibley @hopkinskimmel @sibleyonline
Baltimore, MD
Joined February 2013
RT @DDoroshow: As my thoughtful colleagues provide advice for #ASCO25 attendees, here’s a list of stupid stuff to avoid (guilty as charged)….
0
13
0
RT @OncBrothers: Treatment Algorithm: This is the algorithm we have use during our discussion w/ @SusanScottMD for mNSCLC with potential ac….
0
44
0
RT @OncBrothers: Treatment Algorithm series: mNSCLC w/ actionable mutations in 1L with @SusanScottMD . ✅ EGFR.✅ ALK.✅ ROS1/BRAF/RET/NTRK/Me….
0
12
0
RT @OncLive: We asked 5 top lung cancer experts which #ASCO2025 presentations are a must-see—and why. 🎙️ Featuring: @JSabari, @PatelOnco….
0
3
0
RT @OncLive: ✨EXCLUSIVE✨: Lung cancer experts discuss the evolving use of antibody-drug conjugates in non–small cell lung cancer. @Latinamd….
onclive.com
Lung cancer experts discuss successes and hesitations regarding the evolving use of antibody-drug conjugates in non–small cell lung cancer.
0
2
0
RT @OncBrothers: @ADesaiMD @JTOonline @LungCancerRx @oncodaily Thanks for sharing this, @ADesaiMD! Just yesterday we were talking about thi….
0
1
0
Join me and a distinguished roster of renowned experts at the D.C. Lung Cancer Conference 2025! This conference will focus on practical, up-to-date strategies for clinicians from all disciplines who care for patients with Lung Cancer. Register today at
1
4
19
RT @BalazsHalmosMD: @MariamAlex26 @lungoncdoc @TLCconference @StephenVLiu @ZPiotrowskaMD @JoelNealMD @SusanScottMD Susie is a legend and OS….
0
1
0
0
7
0
RT @StephenVLiu: #TexasLung25 Dr. @LeXiuning sets the stage by discussing 1L therapy in #EGFR NSCLC, comparing and contrasting various stra….
0
23
0
RT @StephenVLiu: Had a great time with @SusanScottMD discussing #HER2 and lunging cancer with Peer Direct!
0
2
0
RT @JulieBrahmer: Excellent debate at #WLC25 by @SusanScottMD and @BalazsHalmosMD both deserved a trophy but Dr Scott delivered the kno….
0
6
0
RT @BalazsHalmosMD: @JulieBrahmer @SusanScottMD Very well deserved by my young and worthy challenger!. But can someone tell me where i can….
0
1
0
RT @Latinamd: #WLC25 @SusanScottMD @HopkinsThoracic knocked it out of the park⚾️🏟️winning 🥇argument that osimertinib monotherapy is no long….
0
12
0
RT @NaglaAKarimMD: @SusanScottMD discussing first line EGFR therapies #Flaura2 #MARIPOSA lots of evolving data #DCLung24 @StephenVLiu h….
0
4
0
RT @StephenVLiu: First-line treatment for #EGFR NSCLC is more complex, with approvals for osimertinib (FLAURA), osi + chemo (FLAURA2), and….
0
30
0
RT @StephenVLiu: Congratulations to Dr. Julie Brahmer @JulieBrahmer - this year’s Paul A. Bunn Jr. Scientific Award winner for lifetime ach….
0
11
0
RT @BrunaPellini: 🚨Why should we study circulating tumor DNA (ctDNA)?🧬 Discover how my research on #ctDNA aims to uncover cancer drivers, e….
0
17
0
RT @EGFRSummit: 🌟 Unlock new possibilities in #LungCancer #Research. Submit your abstract by Sept 30 ➡ @jillfeldman….
0
7
0